Shots: The collaboration allows MD Anderson to conduct multiple clinical studies for multiple rare cancer indications. MD Anderson plans to develop an approach, upon commercialization in rare diseases and will receive royalties on sales of the product in the US, used it to fund for uninsured patients The focus of the collaboration is to advance […]Read More
